Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 22;16(1):7512.
doi: 10.1038/s41598-026-40449-y.

Synthesis and biological evaluation of 6-hydroxychromone based thiosemicarbazones as potential antidiabetic and antioxidant agents

Affiliations
Free article

Synthesis and biological evaluation of 6-hydroxychromone based thiosemicarbazones as potential antidiabetic and antioxidant agents

Wajeeha Zareen et al. Sci Rep. .
Free article
No abstract available

Keywords: 6-Hydroxychromone; Antidiabetic; Antioxidant; Enzyme inhibition; Molecular docking; Thiosemicarbazones.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

References

    1. Cheng, X. et al. Quercetin: A promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis. Phytomedicine 126, 154887 (2024). - PubMed - DOI
    1. Su, M. et al. Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: A research review. Front. Immunol. https://doi.org/10.3389/fimmu.2023.1243834 (2023). - DOI - PubMed - PMC
    1. Li, M. et al. Identification of 1,3,4-thiadiazolyl-containing thiazolidine-2,4-dione derivatives as novel PTP1B inhibitors with antidiabetic activity. J. Med. Chem. 67(10), 8406–8419 (2024). - PubMed - DOI
    1. Shao, D.-W., Zhao, L.-J. & Sun, J.-F. Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM). Eur. J. Med. Chem. 272, 116464 (2024). - PubMed - DOI
    1. Zhou, Y. et al. Arctigenin mitigates insulin resistance by modulating the IRS2/GLUT4 pathway via TLR4 in type 2 diabetes mellitus mice. Int. Immunopharmacol. 114, 109529 (2023). - PubMed - DOI

LinkOut - more resources